Keystone Microtech Corporation (TPEX:6683)

Ligand Pharmaceuticals Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,964	1,736	1,410	1,529	1,482	1,229
Revenue Growth (YoY)	34.00%	23.11%	-7.78%	3.21%	20.60%	49.05%
Cost of Revenue	970.55	815.87	704.63	781.29	676.2	523.99
Gross Profit	992.97	920.22	705.6	747.94	805.52	704.67
Selling, General & Admin	184.08	172.24	112.71	102	88.72	86.11
Research & Development	272.71	248.47	166.12	196.3	183.39	174.72
Operating Expenses	466.44	424.99	282.5	301.1	264.8	268.34
Operating Income	526.53	495.23	423.1	446.84	540.72	436.33
Interest Expense	-0.42	-0.39	-0.46	-0.2	-0.2	-0.13
Interest & Investment Income	21.7	26.49	22.15	3.55	1.76	5
Currency Exchange Gain (Loss)	62.7	62.7	-2.48	62.61	-15.3	-28.26
Other Non Operating Income (Expenses)	-131.08	0.23	0.37	0.16	-0.25	-0.14
EBT Excluding Unusual Items	479.43	584.25	442.68	512.96	526.72	412.81
Other Unusual Items	-	-	0.03	-	-	-
Pretax Income	479.43	584.25	442.71	512.96	526.72	412.81
Income Tax Expense	90.64	104.43	88.51	106.51	107.02	78.81
Net Income	388.79	479.82	354.2	406.45	419.7	334
Net Income to Common	388.79	479.82	354.2	406.45	419.7	334
Net Income Growth	-5.47%	35.47%	-12.86%	-3.16%	25.66%	61.42%
Shares Outstanding (Basic)	27	27	27	27	27	27
Shares Outstanding (Diluted)	28	28	27	27	27	27
Shares Change (YoY)	0.70%	0.54%	-0.40%	0.66%	0.13%	2.69%
EPS (Basic)	14.32	17.69	13.07	15.01	15.50	12.34
EPS (Diluted)	14.11	17.44	12.95	14.80	15.38	12.25
EPS Growth	-6.17%	34.67%	-12.50%	-3.77%	25.55%	57.05%
Free Cash Flow	144.64	-30.12	467.99	363.86	282.06	221.04
Free Cash Flow Per Share	5.25	-1.09	17.11	13.24	10.34	8.11
Dividend Per Share	-	10.000	6.510	7.500	7.800	5.500
Dividend Growth	-	53.61%	-13.20%	-3.85%	41.82%	37.50%
Gross Margin	50.57%	53.01%	50.03%	48.91%	54.36%	57.35%
Operating Margin	26.82%	28.53%	30.00%	29.22%	36.49%	35.51%
Profit Margin	19.80%	27.64%	25.12%	26.58%	28.32%	27.18%
Free Cash Flow Margin	7.37%	-1.74%	33.19%	23.79%	19.04%	17.99%
EBITDA	582.89	542.53	471.36	492.06	578.21	467.44
EBITDA Margin	29.69%	31.25%	33.42%	32.18%	39.02%	38.04%
D&A For EBITDA	56.35	47.3	48.26	45.22	37.49	31.11
EBIT	526.53	495.23	423.1	446.84	540.72	436.33
EBIT Margin	26.82%	28.53%	30.00%	29.22%	36.49%	35.51%
Effective Tax Rate	18.91%	17.87%	19.99%	20.76%	20.32%	19.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.